TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD)

Ito, 2008, Chemistry of mixed melanogenesis – pivotal roles of dopaquinone, Photochem Photobiol, 84, 582, 10.1111/j.1751-1097.2007.00238.x Prota, 1993, Regulatory mechanisms of melanogenesis: beyond the tyrosinase concept, J Invest Dermatol, 100, 156S, 10.1038/jid.1993.69 Boissy, 2004, On the etiology of contact/occupational vitiligo, Pigment Cell Res, 17, 208, 10.1111/j.1600-0749.2004.00130.x Jimbow, 1974, Mechanism of depigmentation by hydroquinone, J Invest Dermatol, 62, 436, 10.1111/1523-1747.ep12701679 Nordlund, 1985, Dermatitis produced by applications of monobenzone in patients with active vitiligo, Arch Dermatol, 121, 1141, 10.1001/archderm.1985.01660090055013 van den Boorn, 2011, Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy, J Invest Dermatol, 131, 1240, 10.1038/jid.2011.16 Hariharan, 2010, Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation, J Invest Dermatol, 130, 211, 10.1038/jid.2009.214 Ito, 1987, Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes, Biochem Pharmacol, 36, 2007, 10.1016/0006-2952(87)90501-6 Tandon, 1998, Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol, Biochem Pharmacol, 55, 2023, 10.1016/S0006-2952(98)00090-2 Alena, 1994, Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine, Cancer Res, 54, 2661 Thomas, 1999, Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs, J Invest Dermatol, 113, 928, 10.1046/j.1523-1747.1999.00781.x Ishii-Osai, 2012, N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model, J Dermatol Sci, 67, 51, 10.1016/j.jdermsci.2012.04.009 Schroder, 2010, The inflammasomes, Cell, 140, 821, 10.1016/j.cell.2010.01.040 Berg, 2003, Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen, J Exp Med, 198, 1583, 10.1084/jem.20031051 Bou Ghanem, 2009, Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection, Infect Immun, 77, 1492, 10.1128/IAI.01207-08 Kupz, 2012, NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8(+) T cells, Nat Immunol, 13, 162, 10.1038/ni.2195 Padgette, 1984, Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine beta-hydroxylase, J Med Chem, 27, 1354, 10.1021/jm00376a024 Prezioso, 1992, Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells, Cancer Lett, 63, 73, 10.1016/0304-3835(92)90092-A Sato, 2009, N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells, J Invest Dermatol, 129, 2233, 10.1038/jid.2009.39 Eisenbarth, 2008, Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants, Nature, 453, 1122, 10.1038/nature06939 Mariathasan, 2006, Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, 440, 228, 10.1038/nature04515 Jones, 2010, Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis, Proc Natl Acad Sci U S A, 107, 9771, 10.1073/pnas.1003738107 Dinarello, 1998, Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme, Ann N Y Acad Sci, 856, 1, 10.1111/j.1749-6632.1998.tb08307.x Tschopp, 2010, NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?, Nat Rev Immunol, 10, 210, 10.1038/nri2725 Hausmann, 2000, Gel clot LAL assay in the initial management of peritoneal dialysis patients with peritonitis: a retrospective study, Nephrol Dial Transplant, 15, 680, 10.1093/ndt/15.5.680 Ito, 2012, Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models, Biochem Pharmacol, 84, 646, 10.1016/j.bcp.2012.06.015 Kanneganti, 2007, Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling, Immunity, 26, 433, 10.1016/j.immuni.2007.03.008 Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta, Nat Immunol, 9, 857, 10.1038/ni.1636 Hornung, 2008, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, Nat Immunol, 9, 847, 10.1038/ni.1631 Bruchard, 2013, Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat Med, 19, 57, 10.1038/nm.2999 Cassel, 2008, The Nalp3 inflammasome is essential for the development of silicosis, Proc Natl Acad Sci U S A, 105, 9035, 10.1073/pnas.0803933105 Dostert, 2008, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, Science, 320, 674, 10.1126/science.1156995 Allen, 2010, The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer, J Exp Med, 207, 1045, 10.1084/jem.20100050 Ghiringhelli, 2009, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, Nat Med, 15, 1170, 10.1038/nm.2028 Stagg, 2010, Extracellular adenosine triphosphate and adenosine in cancer, Oncogene, 29, 5346, 10.1038/onc.2010.292 Tough, 1997, T cell stimulation in vivo by lipopolysaccharide (LPS), J Exp Med, 185, 2089, 10.1084/jem.185.12.2089